Technology area: Chemistry & Materials
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days
Integra Biosciences AG has 3 pending office actions in the Chemistry & Materials technology area. These 3 actions are spread across 3 distinct examiners and 3 distinct art units, creating a direct ratio for every metric. NOGUEROLA, ALEXANDER STEPHAN is the busiest examiner, currently managing 1 pending action. This means that every pending action for the company is being handled by a different examiner in a different art unit.
Such a distribution suggests that the company's current filings in Chemistry & Materials are technically distinct from one another. The lack of overlap in examiners or art units for these 3 actions indicates a diversified set of patent applications within the current prosecution cycle. For a practitioner, this profile requires navigating 3 different examiner styles and 3 separate art unit environments. The 1 pending action assigned to NOGUEROLA, ALEXANDER STEPHAN is part of this highly fragmented prosecution landscape.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| Double-patenting only | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NOGUEROLA, ALEXANDER STEPHAN | 1 | 82.8% | +3.0% |
| KWAK, DEAN P | 1 | 58.8% | +37.1% |
| HERBERT, MADISON TAYLOR | 1 | 59.1% | +53.7% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19031280 | EVAPORATION MANAGEMENT IN DIGITAL MICROFLUIDIC DEVICES | NOGUEROLA, ALEXANDER STEPHAN | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18601304 | PIPETTE TIP AND MOUNTING SHAFT | KWAK, DEAN P | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18064893 | DIGITAL MICROFLUIDICS DEVICES AND METHODS OF USE THEREOF | HERBERT, MADISON TAYLOR | 26d |
| 18601304 | PIPETTE TIP AND MOUNTING SHAFT | KWAK, DEAN P | — |
| Art Unit | Apps |
|---|---|
| 1795 | 1 |
| 1798 | 1 |
| 1758 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19031280 | EVAPORATION MANAGEMENT IN DIGITAL MICROFLUIDIC DEVICES | NOGUEROLA, ALEXANDER STEPHAN | 1795 | DP | Non-Final OA | — | Pending | Jan 17, 2025 |
| 18601304 | PIPETTE TIP AND MOUNTING SHAFT | KWAK, DEAN P | 1798 | §103§112 | Non-Final OA | — | Pending | Mar 11, 2024 |
| 18064893 | DIGITAL MICROFLUIDICS DEVICES AND METHODS OF USE THEREOF | HERBERT, MADISON TAYLOR | 1758 | §103Other | Final Rejection | 26d | Pending | Dec 12, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialIntegra Biosciences AG has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Alexander Stephan Noguerola has the most, with 1 of Integra Biosciences AG's pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
